Transposition of Great Vessels
21
4
6
13
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 21 trials
100.0%
+13.5% vs benchmark
19%
4 trials in Phase 3/4
8%
1 of 13 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 13 completed trials
Clinical Trials (21)
NIRS in Congenital Heart Defects - Correlation With Echocardiography
Effects Branch PA Stenting d-TGA, ToF and TA
MASA Valve Early Feasibility Study
Cardiac Resynchronization Therapy in Adult Congenital Heart Disease With Systemic Right Ventricle: RIGHT-CRT
Fibrosis, Valvular and Ventricular Function in Patients With TGA
Nitric Oxide During Bypass for Arterial Switch Operation
Comprehensive Long-term Follow up of Adults With Arterial Switch Operation
Influence of Timing of Switch Operation in Transposition of Great Arteries
Outcomes of Transposition of the Great Arteries After Arterial Switch Operation
Sudden Cardiac Death in Systemic Right Ventricle
A Retrospective Comparison of the Efficacy and Safety of Celsior® in Pediatric Cardiac Surgery for Transposition of the Great Vessels
Canadian Adult Congenital Heart Disease Intervention Registry
Late Function After Surgery for Transposition of the Great Arteries
MRI Study After Arterial Switch Operation in Patients With Transposition of the Great Arteries
Eplerenone in Systemic Right Ventricle
Infant Heart Surgery: Central Nervous System Sequelae of Circulatory Arrest
Comparison of Hematocrit Levels in Infant Heart Surgery
Reproduction and Survival After Cardiac Defect Repair
Physical Training in Transposition of the Great Arteries
N-Acetylcysteine in Neonatal Congenital Heart Surgery (INACT Study)